AI-generated from publicly available materials.The Society for Clinical Research Sites (SCRS) has introduced a new data intelligence tool, the Eagle Insights Dashboard, designed to enhance the evaluation of clinical trial site performance.
This innovative platform allows clinical trial sponsors and Contract Research Organizations (CROs) to assess their effectiveness through a comprehensive scoring system. The score aggregates various metrics, including study start-up efficiency, communication quality, and the diversity of patient populations. By leveraging site feedback, organizations can pinpoint engagement weaknesses, benchmark their performance against industry peers, and make better-informed decisions regarding investments and processes.
SCRS emphasizes that these insights can foster stronger partnerships with clinical trial sites, promoting a more collaborative atmosphere within the research community. The dashboard is expected to evolve, incorporating data from upcoming years to facilitate long-term trend analysis.
Notably, a prominent global biopharmaceutical company has already integrated the dashboard into its operations, reflecting a commitment to enhancing site relationships. According to Jimmy Bechtel from SCRS, this tool not only measures site relationship effectiveness but also provides actionable insights, enabling organizations to base their strategies on factual data rather than assumptions.